M&A · Healthcare · Buyer's industry: In Vitro & In Vivo Diagnostic Substances
OncoCyte Corp to acquire Chronix Biomedical
Announced Feb 2, 2021 · Closed Apr 19, 2021 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock
Transaction
- Acquirer
- OncoCyte Corp (OCX)
- Target
- Chronix Biomedical
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Apr 19, 2021
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- In Vitro & In Vivo Diagnostic Substances